Deutsch English Français

Contact

EP3188734

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3188734

EP3188734 - METHOD OF TREATING ORGANOPHOSPHATE INTOXICATION [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 16.04.2021 Database last updated on 07.10.2024
Former	Examination is in progress Status updated on 05.01.2018
Former	Request for examination was made Status updated on 15.06.2017
Former	The international publication has been made Status updated on 21.03.2017
Most recent event Tooltip	16.04.2021	Application deemed to be withdrawn	published on 19.05.2021 [2021/20]
Applicant(s)	For all designated states The Texas A&M University System 3369 Tamu College Station Bryan, Texas 77843-3369 / US
	[2017/28]
Inventor(s)	01 / REDDY, Doodipala, Samba 2481 Newark Circle College Station, TX 77845 / US
	[2017/28]
Representative(s)	McNab, Donald C., et al Marks & Clerk LLP 40 Torphichen Street Edinburgh EH3 8JB / GB
	[N/P]
Former [2017/28]	McNab, Donald C. Marks & Clerk LLP Atholl Exchange 6 Canning Street Edinburgh EH3 8EG / GB
Application number, filing date	15838694.6	01.09.2015
	[2017/28]
	WO2015US47914
Priority number, date	US201462044635P	02.09.2014 Original published format: US 201462044635 P
	[2017/28]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2016036724
	Date:	10.03.2016
	Language:	EN
	[2016/10]
	Type:	A1 Application with search report
	No.:	EP3188734
	Date:	12.07.2017
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 10.03.2016 takes the place of the publication of the European patent application.
	[2017/28]
Search report(s)	International search report - published on:	US	10.03.2016
	(Supplementary) European search report - dispatched on:	EP	11.12.2017
Classification	IPC:	A61K31/56, A61K31/565, A61K31/57, A61K31/573, A61P25/00, A61P25/28	[2018/02]
	CPC:	A61K31/57 (EP,US); A61K31/565 (EP,US); A61K31/573 (EP,US); A61P25/00 (EP); A61P25/28 (EP)
	Former IPC [2017/28]	A61K31/56, A61K9/48, A61P25/28
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/28]
Extension states	BA	21.03.2017
	ME	21.03.2017
Validation states	MA	21.03.2017
Title	German:	VERFAHREN ZUR BEHANDLUNG EINER ORGANOPHOSPHATVERGIFTUNG	[2017/28]
	English:	METHOD OF TREATING ORGANOPHOSPHATE INTOXICATION	[2017/28]
	French:	MÉTHODE DE TRAITEMENT DE L'INTOXICATION PAR ORGANOPHOSPHATES	[2017/28]
Entry into regional phase	21.03.2017	National basic fee paid
	21.03.2017	Search fee paid
	21.03.2017	Designation fee(s) paid
	21.03.2017	Examination fee paid
Examination procedure	21.03.2017	Examination requested [2017/28]
	21.03.2017	Date on which the examining division has become responsible
	12.10.2017	Amendment by applicant (claims and/or description)
	08.01.2018	Despatch of a communication from the examining division (Time limit: M06)
	25.06.2018	Reply to a communication from the examining division
	18.05.2020	Despatch of a communication from the examining division (Time limit: M06)
	01.12.2020	Application deemed to be withdrawn, date of legal effect [2021/20]
	11.01.2021	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2021/20]
Fees paid	Renewal fee
	25.09.2017	Renewal fee patent year 03
	11.09.2018	Renewal fee patent year 04
	13.09.2019	Renewal fee patent year 05
	23.09.2020	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XI] - LUMLEY L A ET AL, "Anticonvulsant and neuroprotectiveeffects of the neurosteroidpregnanolone against soman exposure in rats", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER 2008, SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER 2008, SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER 2008, (20080101), vol. 38, XP009502080 [X] 1-4,7,9,11,12,14,15 * abstract * [I] 5,6,8,10,13
		[XI] - SCHWARTZ J E ET AL, "Soman-induced seizures and brain pathology are reduced in rats by the neurosteroidallopregnanolone administered in combination with diazepam", SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER 2010, SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER 2010, SOCIETY FOR NEUROSCIENCE ABSTRACT VIEWER AND ITINERARY PLANNER 2010, (20100101), vol. 40, XP009502079 [X] 1-4,7,9,11,12,14,15 * abstract * [I] 5,6,8,10,13
		[XI] - SHARMA AMIT K ET AL, "Effect of progesterone on phosphamidon-induced impairment of memory and oxidative stress in rats", HUMAN & EXPERIMENTAL TOXICOLOGY, SAGE PUBLICATIONS LTD, GB, (20110930), vol. 30, no. 10, doi:10.1177/0960327110396522 PUBMED:21257640, ISSN 1477-0903, pages 1626 - 1634, XP009502077 [X] 1-4,9,11,12,14,15 * abstract * * page 1627 * [I] 5-8,10,13 DOI: http://dx.doi.org/10.1177/0960327110396522 pubmed:21257640
	International search	[XY]WO2014028398 (UNIV CALIFORNIA [US], et al) [X] 1, 3, 9, 11-19, 56, 58, 64, 66-73, 75, 77, 81-92 * ; paragraphs [0007], [0009]-[0010], [0037], [0040], [0044]-[0045], [0052], [0055]-[0056], [0066], [0131]-[0132]; claims 1, 8, 20-21, 47 * [Y] 4-8, 10, 20, 22-39, 41-55, 57, 59-63, 65, 74, 78-80;
		[XY]WO2013043985 (UNIV CALIFORNIA [US], et al) [X] 1-2, 75-76 * ; paragraphs [0011], [0037]; claims 1, 3, 19-21 * [Y] 20-21, 39-40;
		[Y]WO2014100231 (KOTZKER CONSULTING LLC [US]) [Y] 7-8, 26-27, 62-63 * ; page 5, line 21; page 6, lines 1-2, line 9, lines 24-26 *;
		[Y]US8604066 (BAUD FREDERIC J [FR], et al) [Y] 20-38, 42-43, 57 * ; column 5, lines 50-51; claims 1, 8 *;
		[Y]US5521215 (KLOOG YOEL [IL], et al) [Y] 39-41, 44-55, 74 * ; column 3, lines 26-32; column 6, lines 21-29 *;
		[Y] - LALLEMENT, G, "Medical management of organophosphate-induced seizures.", Journal of Physiology, Paris)., (19980000), vol. 92, pages 369 - 373, XP055416548 [Y] 4-6, 23-25, 42-44, 59-61, 78-80 * ; abstract; page 372, right column, 5th paragraph * DOI: http://dx.doi.org/10.1016/S0928-4257(99)80007-2
		[Y] - VENKATESH, S, "Progression of Type I to Type II paralysis in acute organophosphorous poisoning: Is oxidative stress significant?;", Archives of Toxicology., (20060000), vol. 80, doi:doi:10.1007/s00204-005-0053-1, pages 354 - 361, XP 019419722 [Y] 10, 29, 65 * ; abstract *
		[Y] - EDDLESTON, M, "Management of acute organophosphorus pesticide poisoning.", LANCET., (20080000), vol. 371, pages 597 - 607, XP022482851 [Y] 6, 25, 44, 61, 80 * ; page 600, summary of treatment * DOI: http://dx.doi.org/10.1016/S0140-6736(07)61202-1
		[Y] - FLOWER, O et al., "Sedation in Traumatic Brain Injury.", Emergency Medicine International., vol. 2012, no. 637171, pages 1 - 12, XP055416552 [Y] 45 * ; page 1, right column, 2nd paragraph; page 4, left column, last paragraph * DOI: http://dx.doi.org/10.1155/2012/637171
		[Y] - INSTITUTE OF MEDICINE., "Veterans and Agent Orange.", The National Academies., (19960000), URL: http://www.ncbi.nlm.nih.gov/books/NBK232842/pdf/Bookshelf_NBK232842.pdf, (20151022), XP055416557 [Y] 47 * ; page 304, 2nd paragraph; page 310, 4th paragraph *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p